GlassScriptPhysician profile
John Thomas Herion
NPI 1902331275
$4,158.60
in general payments reported to CMS, 2019-2025
17 companies · $2,798 in 2025
The $2,798 reported for 2025 was more than what 96% of Internal Medicine providers received nationally (typical 2025 total: $156).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $12.73 · 2022: $46.00 · 2023: $325 · 2024: $977 · 2025: $2,798.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Consulting Fee: $2,125 · Food and Beverage: $1,975.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Consulting Fee | $2,125.00 |
| Food and Beverage | $1,974.87 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Abbvie INC. | $2,740.21 | 2023-2025 | |
| Astrazeneca Pharmaceuticals LP | $312.56 | 2022-2025 | Saphnelo |
| Janssen Biotech, INC. | $220.97 | 2022-2025 | Tremfya, Simponi Aria |
| Amgen INC. | $199.09 | 2023-2025 | Otezla, Krystexxa, Tavneos |
| Ucb, INC. | $195.82 | 2022-2025 | Bimzelx, Cimzia |
| Lilly USA, LLC | $89.45 | 2023-2025 | Taltz, Zepbound, Olumiant |
| Organon LLC | $78.53 | 2023-2025 | Hadlima |
| Fresenius Kabi USA, LLC | $64.70 | 2023-2025 | Idacio |
| Radius Health, INC. | $48.13 | 2025 | Tymlos |
| Novartis Pharmaceuticals Corporation | $47.06 | 2024-2025 | |
| Aurinia Pharma U.S., INC. | $36.22 | 2023-2024 | Lupkynis |
| Actelion Pharmaceuticals US, INC. | $26.04 | 2023 | Opsumit, Uptravi |
| Genentech USA, INC. | $22.89 | 2025 | Actemra |
| Genzyme Corporation | $22.83 | 2024 | |
| E.R. Squibb & Sons, L.L.C. | $22.67 | 2023 | Orencia |
Show all 17 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Pfizer INC. | $18.70 | 2023 | |
| Edwards Lifesciences Corporation | $12.73 | 2019 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw John Herion listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.